Klaria Pharma Holding AB publ. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue - ar was SEK 0 compared to SEK 1.107 million a year ago. Operating loss was SEK 13.906 million compared to SEK 9.359 million a year ago. Net loss was SEK 15.931 million compared to SEK 10.110 million a year ago. Basic loss per share from continuing operations was SEK 0.31 compared to SEK 0.24 a year ago. For the half year, total revenue was SEK 31.310 million compared to SEK 2.579 million a year ago. Operating income was SEK 3.620 million compared to operating loss of SEK 19.613 million a year ago. Net income was SEK 778,000 compared to net loss of SEK 21.139 million a year ago. Basic earnings per share from continuing operations was SEK 0.02 compared to basic loss per share from continuing operations of SEK 0.55 a year ago.